Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCombined Modality TherapyCisplatinDoxorubicinCyclophosphamideToxicity TestsDisease-Free SurvivalDrug Administration ScheduleNeoadjuvant TherapyEtoposideSurvival AnalysisBreast NeoplasmsNeoplasm StagingSurvival RateLung NeoplasmsMethotrexatePrognosisPaclitaxelCarboplatinVinblastineTaxoidsNeoplasmsNeoplasm Recurrence, LocalDeoxycytidineAntimetabolites, AntineoplasticInduction ChemotherapyIfosfamideOrganoplatinum CompoundsToxicity Tests, AcuteDose-Response Relationship, DrugDrug Resistance, NeoplasmBleomycinAntineoplastic Agents, AlkylatingAntineoplastic Agents, PhytogenicNeutropeniaSalvage TherapyTime FactorsCarcinoma, Non-Small-Cell LungCytarabineFollow-Up StudiesNeoplasm MetastasisAnthracyclinesChemotherapy, Cancer, Regional PerfusionNauseaInfusions, IntravenousOvarian NeoplasmsVomitingAdenocarcinomaRadiotherapyCamptothecinLeukopeniaLymphoma, Non-HodgkinAntibiotics, AntineoplasticTransplantation, AutologousRadiotherapy, AdjuvantColorectal NeoplasmsTesticular NeoplasmsDacarbazineHodgkin DiseaseClinical Trials as TopicRadiotherapy DosageCarmustineProspective StudiesGranulocyte Colony-Stimulating FactorBrain NeoplasmsMelphalanKaplan-Meier EstimateLomustineCell Line, TumorMitomycinNeoplasms, Germ Cell and EmbryonalBone NeoplasmsPlatinum CompoundsAntibodies, Monoclonal, HumanizedLiver NeoplasmsInfusions, Intra-ArterialMitoxantroneThrombocytopeniaHematopoietic Stem Cell TransplantationThiotepaTegafurRecurrencePeritoneal NeoplasmsOsteosarcomaAntibodies, MonoclonalStomach NeoplasmsAdministration, OralCarcinoma, Squamous CellAntiemeticsPalliative CareDisease ProgressionTumor Markers, BiologicalDaunorubicinDrug EvaluationDrug TherapyCarcinomaLethal Dose 50